ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$7.17
+6.62%
Mkt Cap $7.59B
Analyst Ratings
Buy
22
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
Implied Upside
+88.4%
Consensus $13.50 vs current $7.17
NASDAQ·Healthcare·Biotechnology
$7.17
+6.62%
Mkt Cap $7.59B
Buy
22
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
+88.4%
Consensus $13.50 vs current $7.17